AcquiredStartups
Home/North America/Healthtech & bio
Merger · Healthtech & bio · United States

Berry Street merges with Khosla-backed Healthify to build AI-assisted metabolic care in the US

The deal pairs a three-year-old US network of more than 2,000 insurance-covered clinicians with Healthify's AI nutrition assistant Ria, and the two founders will run the combined company as co-CEOs.

ASAcquired deals deskNorth America24 August 2026 · 4 min read
Healthify acquires Berry Street
Photo: TudorTulok / Wikimedia Commons, CC BY-SA 4.0

Berry Street, a New York nutrition care startup that connects patients with registered dietitians through their health insurance, merged with Healthify, a Bengaluru-based AI health app backed by Khosla Ventures. The deal was reported by Fierce Healthcare, which received the news first, and by Inc42 on 24 August 2026. Executives described the combined business as the largest insurance-covered AI metabolic health platform in the United States.

The companies did not disclose financial terms. Venture Intelligence reported that Healthify's existing investors will stay invested in the merged company.

Berry Street founder and chief executive Noah Kotlove and Healthify chief executive Tushar Vashisht will lead the combined company as co-CEOs. The business will keep the Berry Street name in the US, while the Healthify brand will remain in India and the other markets where it already has users.

What Berry Street built

Kotlove and Jesse Rose launched Berry Street in New York in 2023. The idea was to help registered dietitians run private practices that bill health insurers, so that patients can see a dietitian one-on-one at little or no cost. Berry Street says 95% of its patients pay nothing out of pocket for dietitian visits, and it works with more than 1,250 insurance plans.

According to Fierce Healthcare, the company now has a network of more than 2,000 clinicians across all 50 states and has served more than 200,000 patients, including through partnerships with Amazon, Walmart and other health plans and consumer platforms. It covers more than 30 conditions, from weight loss and diabetes to women's health and heart health.

In 2025 Berry Street added a GLP-1 programme in which patients see a doctor through their insurance and can be prescribed FDA-approved weight loss drugs alongside nutrition therapy. It is also part of the first group of companies in the Centers for Medicare and Medicaid Services' ACCESS model, a 10-year programme for value-based management of chronic conditions.

“Healthify’s mission has been to put a dietitian in every human’s pocket. We have spent a decade proving that AI can drive life-changing outcomes at scale.”Tushar Vashisht, CEO, Healthify
Funding historyTotal raised $50m
2025Venture round$50m

What Healthify brings

Healthify, formerly HealthifyMe, was founded in 2012 by Tushar Vashisht, Mathew Cherian and Sachin Shenoy; Inc42 reported that Cherian and Shenoy have since left. The company started by matching users with dietitians and now says it serves more than 45 million users across more than 20 cultures.

Its main product is Ria, a multilingual AI nutrition coach that Healthify says can log food from a photo in under a second. The company says the assistant was trained on hundreds of millions of conversations between dietitians and patients, and Fierce Healthcare reported that a Stanford study found improvements in weight and metabolic markers among Ria users. Healthify also runs a GLP-1 weight management programme that includes a patient support scheme with Novo Nordisk, which it described as its fastest-growing offering.

Venture Intelligence reported operating income of about INR 178 crore (roughly $21 million) and a net loss of about INR 4.7 crore (roughly $0.6 million) for the 2025 financial year.

Why the two companies combined

Kotlove told Fierce Healthcare that he met the Healthify team in late 2025, when it was looking for a partner to launch in the US, and that its product looked like the next one to two years of Berry Street's own roadmap. The plan is to build Ria into the Berry Street patient app, which already offers AI guidance, meal tracking and data from wearables and lab results between visits.

Kotlove said the ACCESS model, which started in July 2026, pays intentionally low rates, which makes it hard to rely on human clinicians alone. He said the merged company intends to apply Healthify's technology to Medicare patients in the programme's cardio-kidney-metabolic tracks. Healthify will continue to grow in India and plans to enter other countries.

Vashisht said in a statement that Berry Street gives Healthify the clinical backbone and insurance coverage it needed for the US market. Vinod Khosla, founder of Khosla Ventures, also backed the combination in a statement.

The founders and the funding

Berry Street raised $50 million in February 2025 from Northzone, Sofina and FJ Labs, with angel investors including the founder of Revolut, co-founders of Spring Health and Grow Therapy and the chief executive of Found. The company said at the time that the money would go into its consumer nutrition app and its AI tools for dietitian practices.

Healthify raised about $158 million between May 2016 and October 2024, according to Venture Intelligence. Its backers include Khosla Ventures, LeapFrog Investments, Blume Ventures, Chiratae Ventures, Unilever Ventures, HealthQuad and Finnfund. Inc42 reported that Healthify raised $20 million from Khosla Ventures and LeapFrog about two years before the merger to fund its US expansion and AI work.

A crowded market for weight care

The deal comes as GLP-1 drugs reshape weight management in the US. About one in eight Americans now takes a GLP-1 drug, according to KFF data cited by Fierce Healthcare, and Rock Health survey data shows one in three Americans uses AI for health advice, double the share a year earlier.

Both companies argue that general-purpose AI tools are not enough for clinical care, and that the model that works pairs AI with clinicians, insurance coverage and medical oversight.

Sources